Associate Director, Oncology Lifecycle Management - Hematologic Oncology

Associate Director Oncology Lifecycle Management - Hematologic Oncology Position Summary: Natera a Global Leader in cell-free DNA testing focused on changing the management of disease in reproductive health, oncology, and organ transplantation. Signatera is a personalized, tumor-informed test for molecular residual disease (MRD) assessment and surveillance monitoring in patients previously diagnosed with cancer. Signatera is covered by Medicare for colorectal cancer, muscle invasive bladder cancer, high-risk breast cancer, ovarian cancer, lung cancer, and immunotherapy response monitoring for any solid tumor. As an Associate Director of Oncology Lifecycle Management for Hematologic Malignancies you will work in a highly matrixed environment to help shape the strategic direction and drive execution for company success in Hematologic Oncology. Primary Responsibilities: - Own the lifecycle planning and successful product launch for a diagnostic portfolio in Hematologic Malignancies, including Lymphoma, Multiple Myeloma (MM), and Chronic Lymphocytic Leukemia (CLL), collaborating with cross-functional teams to develop and execute a strategic plan that drives usage, awareness, and advocacy across key stakeholders worldwide. - Lead a MM/CLL Lifecycle Team that is a cross-functional team accountable for progress on tumor goals and deploying resources to maximize outcomes. - Establish tumor-specific goals to be owned by the lifecycle team and across functions. - Serve as a critical member of clinical/medical teams, helping define and prioritize key indications while identifying and addressing evidence gaps. - Serve as a critical member on commercial subteams, helping to maximize Natera potential by escalating and addressing critical barriers that limit commercial adoption. - Maintain a deep expertise in the Hematology Oncology space by integrating real-time customer insights, publications, data presentations, competitive and market intelligence. - Drive market access efforts, leading the development of reimbursement dossiers for Medicare/MolDx and commercial payers to secure coverage for non-covered indications. - Develop and execute KOL engagement strategies, collaborating with marketing and medical teams to gather insights, build relationships, and foster advocacy. - Shape the value proposition for Natera’s oncology products in collaboration with Medical Affairs and Commercial Marketing, leveraging clinical evidence and market dynamics. - Co-lead advisory boards and market research efforts in partnership with Medical Affairs. - Regularly present strategic plans and progress to executive leadership. Qualifications: - Bachelor’s degree with 5+ years of relevant experience; advanced degree preferred (MBA or PhD) - Hematologic oncology experience strongly preferred - 5+ years experience in product marketing, market analytics at a pharmaceutical / biotech company - Previous KOL management experience preferred - Working knowledge of oncology molecular testing / biomarkers - ~25% travel required (advisory boards, congresses, sales / marketing meetings, customer meetings) Knowledge, Skills, Abilities: - Ability to lead without authority, influence and inspire individuals - Proven strategic agility with an enterprise mindset and ability to operate with executive presence - Ability to partner and collaborate across a broad range of internal and external partners - Strong customer orientation and focus, particularly establishing thought leader relationships - Proven ability to communicate the complex simply (biomarkers, multiple indications, etc.) - Strong organizational / time management skills; manage and complete multiple projects This is a Remote position – US Based The pay range is listed and actual compensation packages are based on a wide array of factors unique to each candidate, including but not limited to skill set, years & depth of experience, certifications and specific office location. This may differ in other locations due to cos